By Sarah Calkin2012-04-23T13:03:00
Source: llandrea
A pharmaceutical company is taking a primary care trust cluster to court over its decision to encourage the use of a cheaper, unlicensed drug in a case that could be worth millions to the NHS.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud